Overview

Ropinirole in the Treatment of Bipolar Depression

Status:
Completed
Trial end date:
2008-03-17
Target enrollment:
Participant gender:
Summary
To demonstrate efficacy and safety of Requip in in treating bipolar depression.
Phase:
Phase 4
Details
Lead Sponsor:
Cambridge Health Alliance
Collaborators:
Emory University
GlaxoSmithKline
Treatments:
Ropinirole